deflazacort has been researched along with Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marques, MJ; Mauricio, AF; Neto, HS; Pereira, JA | 1 |
| Auricchio, A; Castaldo, S; De Leonibus, E; Di Napoli, D; Faraso, S; Lancioni, A; Nigro, G; Nigro, V; Piluso, G; Rotundo, IL; Russo, F; Russo, V; Vitiello, C | 1 |
| Anderson, JE; Skrabek, RQ | 1 |
3 other study(ies) available for deflazacort and Cardiomyopathies
| Article | Year |
|---|---|
Dual Therapy Deflazacort/Doxycyclyne Is Better Than Deflazacort Monotherapy to Alleviate Cardiomyopathy in Dystrophin-Deficient mdx Mice.
Topics: Animals; Cardiomyopathies; Doxycycline; Drug Therapy, Combination; Dystrophin; Electrocardiography; Female; Male; Mice; Mice, Inbred C57BL; Muscular Dystrophy, Duchenne; Pregnenediones | 2017 |
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy.
Topics: Animals; Blotting, Western; Cardiomyopathies; Cricetinae; Dependovirus; Echocardiography; Genetic Therapy; Genetic Vectors; Male; Mesocricetus; Pregnenediones; Sarcoglycans | 2011 |
Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Northern; Blotting, Western; Cardiomyopathies; Fibroblast Growth Factor 2; Immunohistochemistry; In Situ Hybridization; Laminin; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred mdx; Myocardium; Myosin Heavy Chains; Pregnenediones; Taurine | 2001 |